Childhood choreoathetosis secondary to hyper-IgM syndrome (CD40 ligand deficiency)
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received May 27, 2020
- Accepted in final form August 31, 2020
- First Published October 16, 2020.
Author Disclosures
- Ian C. Coulter, FRCS(SN),
- Han Yan, MD,
- Carolina Gorodetsky, MD,
- Melika Akhbari, MBBS, MSc,
- Sara Breitbart, MSc,
- Suneil K. Kalia, MD, PhD,
- Alfonso Fasano, MD, PhD and
- George M. Ibrahim, MD, PhD
- Ian C. Coulter, FRCS(SN),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Han Yan, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Carolina Gorodetsky, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Melika Akhbari, MBBS, MSc,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Sara Breitbart, MSc,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Suneil K. Kalia, MD, PhD,
NONE
NONE
NONE
(1) Canadian Journal of Neurological Sciences, Editorial Advisory Board, 2016 - present (2) Stereotactic and Functional Neurosurgery, Editorial Advisory Board, 2020 - present.
NONE
NONE
NONE
Medtronic
NONE
NONE
NONE
NONE
(1) CIHR, investigator and/or co-investigator, 2013 - present
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Alfonso Fasano, MD, PhD and
Commercial entities: Abbvie, Boston Scientific, Sunovion and Ipsen.
NONE
Commercial entities: UCB pharma, Medtronic, Abbvie, Chiesi Farmaceutici, TEVA, Boston Scientific, Ipsen
Editorial board member of Movement Disorders, Movement Disorders Clinical Practice and Parkinsonism and Related Disorders
NONE
Book
NONE
Medtronic, Abbvie, Abbott, Ceregate, Boston Scientific
NONE
NONE
NONE
Chiesi Pharmaceutics, Boston Scientific, Medtronic
NONE
NONE
Neureca Onlus, AFaR, the Division of Neurology - University of Toronto and the Michael J. Fox Foundation, Weston Foundation Chair in Neuromodulation and Multidisciplinary Care
NONE
NONE
NONE
NONE
NONE
NONE
- George M. Ibrahim, MD, PhD
NONE
NONE
NONE
NONE
NONE
NONE
NONE …
- From the Division of Neurosurgery (I.C.C., H.Y., M.A., S.B., G.M.I.); Division of Neurology (C.G.), The Hospital for Sick Children; Division of Neurosurgery (S.K.K.), Toronto Western Hospital; Krembil Brain Institute (S.K.K.); and Edmond J. Safra Program in Parkinson's Disease and Morton and Gloria Shulman Movement Disorders Clinic (A.F.), Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada.
- Correspondence
Dr. Ibrahim george.ibrahim{at}sickkids.ca
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.